SCHEMBL1733953

SCHEMBL1733953

CC(C(=O)O)(C(=O)O)C1CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 7/20 0.39
KEAP1 Q14145 1/20 0.39
NFE2L2 Q16236 1/20 0.39
SSTR4 P31391 2/20 0.38
CES2 O00748 1/20 0.36
CES1 P23141 1/20 0.36
ALDH1A1 P00352 2/20 0.35
TSHR P16473 1/20 0.35
PDK1 Q15118 1/20 0.34
PDK2 Q15119 1/20 0.34
PDK3 Q15120 1/20 0.34
PDK4 Q16654 1/20 0.34
GRM2 Q14416 1/20 0.34
GRM3 Q14832 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
HSD17B10 Q99714 1/20 0.33
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
MAPT P10636 1/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21269775 0.98 EPHX1 (0.38) EPHX1KEAP1NFE2L2SSTR4CES2
SCHEMBL21269436 0.98 EPHX1 (0.38) EPHX1KEAP1NFE2L2SSTR4CES2
SCHEMBL21269303 0.98 EPHX1 (0.38) EPHX1KEAP1NFE2L2SSTR4CES2
SCHEMBL28314636 0.98 EPHX1 (0.38) EPHX1KEAP1NFE2L2SSTR4CES2
SCHEMBL28314811 0.98 EPHX1 (0.38) EPHX1KEAP1NFE2L2SSTR4CES2
SCHEMBL28314566 0.98 EPHX1 (0.38) EPHX1KEAP1NFE2L2SSTR4CES2
SCHEMBL11814849 0.97 KEAP1 (0.41) EPHX1KEAP1NFE2L2SSTR4CES2
SCHEMBL28314608 0.95 EPHX1 (0.37) EPHX1KEAP1NFE2L2SSTR4CES2
SCHEMBL28314707 0.95 EPHX1 (0.37) EPHX1KEAP1NFE2L2SSTR4CES2
SCHEMBL28315747 0.95 EPHX1 (0.37) EPHX1KEAP1NFE2L2SSTR4CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042372-B1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE SPA (IT) 2004-07-14 EP claimed
CN-1146585-C catalyst component and catalyst for olefin polymerization ض� 2004-04-21 CN claimed
CN-1292800-A catalyst component and catalyst for olefin polymerization MONTELL TECHNOLOGY COMPANY BV (NL) 2001-04-25 CN claimed
EP-0912617-A1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS Montell Technology Company bv (NL) 1999-05-06 EP claimed
WO-1998056833-A1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS MONTELL TECHNOLOGY COMPANY B.V. (NL) 1998-12-17 WO claimed
WO-2024177038-A1 EASILY ADHESIVE POLYESTER FILM 東洋紡株式会社 2024-08-29 WO disclosed
WO-2024122368-A1 EASILY-ADHESIVE POLYESTER FILM 東洋紡株式会社 2024-06-13 WO disclosed
CN-109233528-B Modified crush-resistant latex topcoat compositions for fiber cement substrates 威士伯采购公司 2021-06-29 CN disclosed
CN-104640886-B The manufacture method of manufacture method for the ingredient of solid catalyst of olefin polymerization, the catalyst for olefin polymerization and olefin polymerization 东邦钛株式会社 2018-04-27 CN disclosed
CN-104640887-B The manufacture method of manufacture method for the ingredient of solid catalyst of olefin polymerization, the catalyst for olefin polymerization and olefin polymerization 东邦钛株式会社 2017-08-29 CN disclosed
CN-105837714-A METHOD FOR PRODUCING SOLID CATALYST COMPONENT FOR USE IN POLYMERIZATION OF OLEFIN, CATALYST FOR USE IN POLYMERIZATION OF OLEFIN, AND METHOD FOR PRODUCING OLEFIN POLYMER 东邦钛株式会社 2016-08-10 CN disclosed
CN-104640887-A Production method for solid catalyst component for polymerizing olefins, catalyst for polymerizing olefins, and production method for polymerized olefins TOHO TITANIUM CO LTD 2015-05-20 CN disclosed
US-20080161558-A1 1-[2-Cyclopentylmethyl-3-(formyl-hydroxy-amino)-propionyl]-pyrrolidine-2-carboxylic acid (5-fluoro-1-oxy-pyridin-2-yl)-amide; inhibitors of peptidyl deformylase (PDF), antimicrobials and antibiotics VICURON HOLDINGS LLC 2008-07-03 US disclosed
CN-101193882-A N-formyl hydroxylamine compounds as PDF inhibitors NOVARTIS AG (CH) 2008-06-04 CN disclosed
EP-1896452-A2 N-FORMYL HYDROXYLAMINE COMPOUNDS Novartis Pharma AG. (CH) 2008-03-12 EP disclosed
WO-2007106670-A2 N-FORMYL HYDROXYLAMINE COMPOUNDS NOVARTIS AG (CH) 2007-09-20 WO disclosed
CN-1984976-A Aqueous vinyl polymer coating compositions DSM IP ASSETS BV (NL) 2007-06-20 CN disclosed
WO-2006127576-A2 N - FORMYL HYDROXYLAMINE COMPOUNDS AS PDF INHIBITORS NOVARTIS AG (CH) 2006-11-30 WO disclosed
CN-1146585-C catalyst component and catalyst for olefin polymerization ض� 2004-04-21 CN disclosed
CN-1292800-A catalyst component and catalyst for olefin polymerization MONTELL TECHNOLOGY COMPANY BV (NL) 2001-04-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161558-A1 1-[2-Cyclopentylmethyl-3-(formyl-hydroxy-amino)-propionyl]-pyrrolidine-2-carboxylic acid (5-fluoro-1-oxy-pyridin-2-yl)-amide; inhibitors of peptidyl deformylase (PDF), antimicrobials and antibiotics PDF, MMP2, PEPD EPHX1 1770/4885KEAP1 3565/4885NFE2L2 3974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.